Table 1. Patient Demographics.

Table showing patient demographics including age, gender, cancer type, stage, treatment received, and timing of detection of TRK fusion.

Factor*	N (%)
Age, Median (Range)	52 (0-78)
Gender
Female	47 (61.8)
Male	29 (38.2)
Cancer Type
Salivary	12 (15.8)
Thyroid	10 (13.2)
Sarcoma NOS	9 (11.8)
Colon	8 (10.5)
Lung	6 (7.9)
Melanoma	5 (6.6)
Glioblastoma Multiforme	4 (5.3)
Pancreatic Cancer	4 (5.3)
Other	18 (23.7)
Stage at Diagnosis (n=58)
Localized, I-III	34 (58.6%)
Metastatic, IV	24 (41.4%)
Prior Therapy
Surgery (n=74)	65 (87.8)
Radiation (n=70)	33 (47.1)
Systemic (n=76)	57 (75)
Class of Systemic Therapy (n=57)
Chemotherapy	39 (68.4)
Immunotherapy	12 (21.1)
TRK Targeted Therapy	39 (68.4)
Intervals, years, median (range)
Diagnosis and TRK Tissue (N=72)	0.2 (0.0-21.4)
Diagnosis and NTRK Sequencing (N=75)	2.0 (0.0-21.6)
TRK Tissue and Sequencing (N=72)	0.3 (0.0-13.0)

^*N=76 for all factors unless otherwise noted